Rhodococcus ruber and application of same as immunologic adjuvant in preparing vaccine

A technology of Rhodococcus erythrococcus and immune adjuvant, which is applied in the field of microbiology and immunology, can solve the problems of unclear efficacy of inactivated vaccine immune adjuvant, low effect of slowly releasing antigen, pathogenicity of humans and animals, etc., to achieve The effect of fast value-added, short fermentation cycle, and less loss of active ingredients

Active Publication Date: 2019-04-05
北京利昂盛生物技术有限公司
View PDF12 Cites 21 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The following problems generally exist in immune adjuvants at present: (1) inactivated Mycobacterium tuberculosis adjuvant, because natural Mycobacterium tuberculosis has high virulence, pathogenicity is arranged to human and animal
At present, attenuated BCG is used to prepare adjuvants, but there are still high requirements for follow-up processing, which is likely to cause incomplete inactivation and cause high animal health risks when used as adjuvants. In addition, it will cause strong inflammation and inflammation at the injection site. Ulcers, limited use
(2) Cytokines have the ability to adjust and rebuild the immune response, but they are expensive and not suitable for animal vaccines
(3) Double-stranded polyinosinic acid (polyinosinic acid) is a kind of artificially s...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rhodococcus ruber and application of same as immunologic adjuvant in preparing vaccine
  • Rhodococcus ruber and application of same as immunologic adjuvant in preparing vaccine
  • Rhodococcus ruber and application of same as immunologic adjuvant in preparing vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 1 (CGMCC NO.16640) Isolation and Identification of Rhodococcus ruber (Rhodococcus ruber) RDC-01

[0038] (1) Soil for testing: Soil samples were taken from the red soil in the suburbs of Guangzhou. The litter layer and roots on the soil surface were removed during sampling to avoid the influence of plants on the soil samples. The sampling depth is 5-10cm. The sampling time was late January 2017, passed through a 10-mesh sieve, and stored at 4°C.

[0039] (2) Strain screening: Take 10 g of fresh soil samples, put them into a conical flask filled with 90 mL of sterile water and glass beads, vibrate to make a bacterial suspension, and dilute it in a test tube. Choose three dilutions (10 -3 —10 -5 ) bacterial suspension was spread on LB medium, cultured at a constant temperature of 37°C, counted and observed the morphological characteristics of the colonies, and counted the types of autogenous bacteria in different soils. Select 6 well-growing strains, pick 5 si...

Embodiment 2

[0045] Embodiment 2 Neutral red method detects rhodococcus erythrococcus to mouse peritoneal macrophage Effects on Phagocytosis

[0046] Macrophages (abbreviated as ) are immune cells, It can activate and regulate lymphocytes or other immune cells to make them respond to pathogens, and can also secrete lymphokines, TNF, interferon, etc. to kill target cells. The neutral red method is to detect One of the commonly used detection methods for phagocytosis. The amount of neutral red phagocytized by macrophages can reflect its phagocytosis function, and the results are represented by A value.

[0047] (1) Experimental animals: 40 BALB / C mice, weighing 18-22 g, all male.

[0048] Medium: peptone 15g / L, yeast powder 15g / L, NaCl 10g / L, glucose 15g / L, NH 4 SO 4 2g / L, pH7.3.

[0049] 0.09% neutral red: Weigh 90 mg of neutral red biological dye, dissolve in 100 mL of normal saline, and sterilize under high pressure at 121°C.

[0050] Cell lysate: 0.1mol / L acetic acid: ethan...

Embodiment 3

[0058] The preparation of embodiment 3 H5 subtype avian influenza oil emulsion inactivated vaccine

[0059] (1) Adjuvant sample processing and quantification

[0060] Take the suspension of Rhodococcus erythrococcus RDC-01 made of sterile normal saline, shake it well, accurately measure 10mL into a glass petri dish, dry it in a blast drying oven at 80°C for 24h, and then weigh it every 1h , until the weight of the two weighings before and after is consistent, calculate the dry weight of the bacteria in the suspension, prepare the suspension with sterile saline to make an adjuvant solution of 100mg / mL (dry weight of the bacteria), and store it at 4°C for future use .

[0061] Take 10 mL of the above-mentioned Rhodococcus erythrococcus RDC-01 adjuvant solution, dissolve it in 10 mL of normal saline, prepare an adjuvant solution with a concentration of 50 mg / mL, and store it at 4°C for future use.

[0062] (2) Preparation of antigen (water phase):

[0063] ①Unadjuvanted contro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses rhodococcus ruber and application of same as an immunologic adjuvant in preparing vaccine. The rhodococcus ruber is also called rhodococcus ruber RDC-01, and the preservation number is CGMCC (China General Microbiological Culture Collection Center) NO. 16640. The rhodococcus ruber disclosed by the invention has the function of increasing and regulating the body immunity andis capable of nonspecifically enhancing the activity of TB (Tuberculosis) lymphocyte, macrophagocyte and NK cells and inducing multiple cell factors such as interferon, and the rhodococcus ruber canbe used as the immunologic adjuvant after being inactivated so as to be added in an oil-adjuvant inactive vaccine, so that generation of an animal antibody induced by the vaccine can be obviously promoted; compared with single use of the oil-adjuvant inactive vaccine, a high-titre antibody can be generated, the use is safe, long-term and short-term toxic and side effects are not generated, and anapplication prospect in the field of preparation of vaccines for animals is good.

Description

technical field [0001] The invention belongs to the field of microbiology and immunology, and in particular relates to a rhodococcus rubococcus and its application as an immune adjuvant in preparing vaccines. Background technique [0002] Inactivated vaccines for various infectious diseases in poultry have played an important role in the prevention and control of these diseases. The use of inactivated vaccines is expected to achieve eliminative immunity, that is, to completely protect the body from the infection of such diseases after being immunized by a certain vaccine, or not to shed the virus after infection, and not to spread the virus to other animals. However, after the existing inactivated vaccine immunizes the body, the antibody is produced slowly, the duration of the antibody is short, and the uniformity of the antibody level is poor. In order to make the antibody level uniform, on the one hand, multiple immunizations are generally required to maintain a high anti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N1/20A61K39/39A61P37/04C12R1/01
CPCA61K39/39A61K2039/552A61K2039/55594A61P37/04C12N1/20C12N1/205C12R2001/01
Inventor 詹少春孙超廖想
Owner 北京利昂盛生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap